T. Rowe Price Associates’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.21M | Buy |
|
|||||
|
2025
Q2 | $497K | Buy |
|
|||||
|
2025
Q1 | $261K | Buy |
|
|||||
|
2024
Q4 | $414K | Buy |
|
|||||
|
2024
Q3 | $434K | Buy |
|
|||||
|
2024
Q2 | $474K | Buy |
|
|||||
|
2024
Q1 | $425K | Buy |
|
|||||
|
2023
Q4 | $157K | Hold |
|
|||||
|
2023
Q3 | $118K | Sell |
|
|||||
|
2023
Q2 | $3.82M | Sell |
|
|||||
|
2023
Q1 | $3.15M | Sell |
|
|||||
|
2022
Q4 | $3.65M | Sell |
|
|||||
|
2022
Q3 | $5.29M | Sell |
|
|||||
|
2022
Q2 | $5.5M | Sell |
|
|||||
|
2022
Q1 | $8.92M | Sell |
|
|||||
|
2021
Q4 | $10.5M | Buy |
|
|||||
|
2021
Q3 | $8.59M | Sell |
|
|||||
|
2021
Q2 | $13M | Sell |
|
|||||
|
2021
Q1 | $24.2M | Sell |
|
|||||
|
2020
Q4 | $46.4M | Buy |
|
|||||
|
2020
Q3 | $12.4M | Sell |
|
|||||
|
2020
Q2 | $9.33M | Sell |
|
|||||
|
2020
Q1 | $9.79M | Sell |
|
|||||
|
2019
Q4 | $13.8M | Buy |
|
|||||
|
2019
Q3 | $8.22M | Buy |
|
|||||
|
2019
Q2 | $11M | Buy |
|